Icon Legend

Presentation Icons

Platinum Award

Gold Award

Silver Award

Bronze Award

Type here to filter the list

Thursday, Nov 16th
10:15 AM - 11:45 AM MST
Genomic Subclassification of Acute Lymphoblastic Leukemia: Cutting Edge Approaches and Practical Considerations
Location: 355BC, Third Level
Co-Moderator: Nathan Montgomery, MD, PhD – NeoGenomics
Co-Moderator (Early Career): Erica Vormittag-Nocito, MD – Northwestern University
OncologyMolecular Methodologies & Technologies
CE: 1.50
Thursday, Nov 16th
10:15 AM - 11:45 AM MST
Polygenic Risk Scores - Implementation and Clinical Utility
Location: 255EF, Second Level
Co-Moderator: Honey Reddi, PhD – Medical College of Wisconsin
Co-Moderator: Meng-Chang Hsiao, PhD – Vanderbilt University Medical Center
AdvocacyInherited ConditionsMolecular Methodologies & Technologies
CE: 1.50
Thursday, Nov 16th
10:15 AM - 11:45 AM MST
Sequencing For Infectious Diseases Diagnosis: Targeted and Agnostic
Location: 251, Upper Concourse
Co-Moderator: Heba Mostafa, MD, PhD, D(ABMM) – Johns Hopkins Medicine
Co-Moderator (Early Career): Krupa Jani, MS, ASCP(iMB) (she/her/hers) – Memorial Sloan Kettering Cancer Center
Infectious DiseasesInformaticsMolecular Methodologies & Technologies
CE: NOT CME/CMLE
Thursday, Nov 16th
10:15 AM - 10:45 AM MST
Clinical Implementation of Polygenic Risk Scores
Location: 255EF, Second Level
Speaker: Aya Abu-El-Haija, MD MPH – Boston Children's Hospital
Inherited ConditionsMolecular Methodologies & Technologies
CE: 1.50
Thursday, Nov 16th
10:15 AM - 10:45 AM MST
NGS for Infectious Diseases Diagnostic Testing – Focusing on the Wet Lab
Location: 251, Upper Concourse
Speaker: Shangxin Yang, PhD, D(ABMM) (he/him/his) – UCLA
Infectious DiseasesInformaticsMolecular Methodologies & Technologies
CE: NOT CME/CMLE
Thursday, Nov 16th
10:15 AM - 11:00 AM MST
Genomic Subclassification of Acute Lymphoblastic Leukemia Using Whole Transcriptome Sequencing and Whole Genome Sequencing
Location: 355BC, Third Level
Speaker: Charles G. Mullighan, MBBS (Hons), MSc, MD – St. Jude Children's Research Hospital
OncologyMolecular Methodologies & Technologies
CE: 1.50
Thursday, Nov 16th
10:45 AM - 11:15 AM MST
DNA Sequence Analysis Overview for Clinical Microbiology Applications
Location: 251, Upper Concourse
Speaker: Ron M. Kagan, PhD – Quest Diagnostics
Infectious DiseasesInformaticsMolecular Methodologies & Technologies
CE: NOT CME/CMLE
Thursday, Nov 16th
10:45 AM - 11:15 AM MST
Implementation of Polygenic Risk Scores - Laboratory Perspectives
Location: 255EF, Second Level
Speaker: Matthew Lebo, PhD (he/him/his) – Lab for Molecular Medicine, Mass General Brigham Personalized Medicine
AdvocacyInherited ConditionsMolecular Methodologies & Technologies
CE: 1.50
Thursday, Nov 16th
11:00 AM - 11:45 AM MST
Practical Approaches to Acute Lymphoblastic Leukemia Classification
Location: 355BC, Third Level
Speaker: Marian Harris, MD, PhD – Harvard Medical School
OncologyMolecular Methodologies & Technologies
CE: 1.50
Thursday, Nov 16th
11:15 AM - 11:45 AM MST
Clinical Metagenomic and Host Response Sequencing for Diagnosis of Infections
Location: 251, Upper Concourse
Speaker: Charles Y. Chiu, MD, PhD (he/him/his) – UCSF
Infectious DiseasesInformaticsMolecular Methodologies & Technologies
CE: NOT CME/CMLE
Thursday, Nov 16th
11:15 AM - 11:45 AM MST
Status of the Use of Polygenic Scores for PGT
Location: 255EF, Second Level
Speaker: Patrick Turley, PhD (he/him/his) – University of Southern California
AdvocacyInherited ConditionsMolecular Methodologies & Technologies
CE: 1.50
Thursday, Nov 16th
2:30 PM - 3:00 PM MST
AMP Working Group: Tumor Mutational Burden Assay Validation and Reporting
Location: 250, Upper Concourse
Speaker: Larissa V. Furtado, MD – St. Jude Children’s Research Hospital
OncologyMolecular Methodologies & Technologies
CE: 1.0
Thursday, Nov 16th
3:00 PM - 3:30 PM MST
Panel Discussion: AMP Working Group: Tumor Mutational Burden Assay Validation and Reporting
Location: 250, Upper Concourse
Panelist: Larissa V. Furtado, MD – St. Jude Children’s Research Hospital
Panelist: Susan Hsiao, MD, PhD – Columbia University Medical Center
Panelist: Jonathan A. Nowak, MD, PhD – Brigham and Women's Hospital
OncologyMolecular Methodologies & Technologies
CE: 1.0
Friday, Nov 17th
10:15 AM - 11:45 AM MST
Recommendations for Cell-Free DNA Assay Validations: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists
Location: 251, Upper Concourse
Co-Moderator: Deepika Sirohi, MD – University of California
Co-Moderator: Susan Hsiao, MD, PhD – Columbia University Medical Center
OncologyInformaticsMolecular Methodologies & Technologies
CE: 1.50
Friday, Nov 17th
10:15 AM - 11:00 AM MST
Wet Lab
Location: 355BC, Third Level
Speaker: Kyle Rodino, PhD, D(ABMM) (he/him/his) – University of Pennsylvania
Infectious DiseasesInformaticsMolecular Methodologies & Technologies
CE: 1.50
Friday, Nov 17th
10:15 AM - 11:45 AM MST
Recommendations for Cell-Free DNA Assay Validations: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists
Location: 251, Upper Concourse
Speaker: Christina Lockwood, PhD (she/her/hers) – University of Washington
OncologyInformaticsMolecular Methodologies & Technologies
CE: 1.50
Friday, Nov 17th
10:45 AM - 11:15 AM MST
Analysis
Location: 355BC, Third Level
Speaker: Will A. Overholt, PhD (he/him/his) – ASRT Inc.
Infectious DiseasesInformaticsMolecular Methodologies & Technologies
CE: 1.50
Friday, Nov 17th
10:55 AM - 11:15 AM MST
Novel Diagnostic DNA Methylation Episignatures Expand and Refine the Epigenetic Landscapes of Mendelian Disorders
Location: 255EF, Second Level
Speaker: Bekim Sadikovic, PhD – London Health Sciences Centre, Western University, London, ON, Canada.
Lab ManagementInherited ConditionsMolecular Methodologies & Technologies
CE: NOT CME/CMLE
Friday, Nov 17th
11:15 AM - 11:45 AM MST
Panel Discussion
Location: 255EF, Second Level
Speaker: Michael E. Talkowski, PhD (he/him/his) – Center for Genomic Medicine of Massachusetts General Hospital, Harvard Medical School
Speaker: Bekim Sadikovic, PhD – London Health Sciences Centre, Western University, London, ON, Canada.
Speaker: Danny Miller, MD, PhD (he/him/his) – University of Washington
Lab ManagementInherited ConditionsMolecular Methodologies & Technologies
CE: NOT CME/CMLE
Friday, Nov 17th
11:15 AM - 11:45 AM MST
Unraveling Epidemics: Scalable Approaches for Elucidating Infectious Disease Dynamics
Location: 355BC, Third Level
Speaker: Karthik Gangavarapu, PhD (he/him/his) – University of California, Los Angeles; Scripps Research
Infectious DiseasesInformaticsMolecular Methodologies & Technologies
CE: 1.50
Friday, Nov 17th
1:15 PM - 1:45 PM MST
CRISPR-based Diagnostics: Fundamental Kinetics and Electrokinetic Assays
Location: 255BC, Second Level
Speaker: Juan G. Santiago, PhD (he/him/his) – Stanford University
Infectious DiseasesMolecular Methodologies & Technologies
CE: NOT CME/CMLE
Friday, Nov 17th
1:15 PM - 1:45 PM MST
Newborn Screening by Genomic Sequencing: Opportunities and Challenges
Location: 355BC, Third Level
Speaker: Wendy Chung, MD, PhD (she/her/hers) – Boston Children's Hospital/Harvard Medical School
AdvocacyInherited ConditionsMolecular Methodologies & Technologies
CE: 1.50
Friday, Nov 17th
1:15 PM - 2:00 PM MST
Spatial Genomics in Solid Tumors
Location: 251, Upper Concourse
Speaker: Andrew Gentles, PhD – Stanford Pathology, Medicine (Biomedical Informatics) and Biomedical Data Science
OncologyMolecular Methodologies & Technologies
CE: 1.50
Friday, Nov 17th
1:15 PM - 2:00 PM MST
Understanding the Current Challenges of the Technologist Workforce in Clinical Genomics Laboratories
Location: 255EF, Second Level
Speaker: Marco L. Leung, PhD, FACMG (he/him/his) – Nationwide Children's Hospital
Lab ManagementMolecular Methodologies & TechnologiesCareer and Leadership Development
CE: 1.50
Friday, Nov 17th
1:45 PM - 2:15 PM MST
Adding Genomic Sequencing and Genetic Risk Scores to the Early Check Newborn Screening Study
Location: 355BC, Third Level
Speaker: Katerina S. Kucera, PhD – RTI International
AdvocacyInherited ConditionsMolecular Methodologies & Technologies
CE: 1.50
Friday, Nov 17th
1:45 PM - 2:15 PM MST
Innovative Technologies in Infectious Disease Diagnosis: CRISPR
Location: 255BC, Second Level
Speaker: Bryan Dechairo, PhD (he/him/his) – Sherlock Biosciences
Infectious DiseasesMolecular Methodologies & Technologies
CE: NOT CME/CMLE
Friday, Nov 17th
2:00 PM - 2:45 PM MST
Creating Internal Training Programs and Incentives to Attract and Maintain Quality Employees
Location: 255EF, Second Level
Speaker: Barbara A. Anderson, PhD – Duke University Health Systems
Lab ManagementMolecular Methodologies & TechnologiesCareer and Leadership Development
CE: 1.50
Friday, Nov 17th
2:00 PM - 2:45 PM MST
The Spatially Resolved Tumor Microenvironment of Hodgkin Lymphoma
Location: 251, Upper Concourse
Speaker: Christian Steidl, MD (he/him/his) – The University of British Columbia
OncologyMolecular Methodologies & Technologies
CE: 1.50
Friday, Nov 17th
2:15 PM - 2:45 PM MST
Exploring Whole Genome Sequencing for Newborn Screening: Lessons from the BabySeq Project
Location: 355BC, Third Level
Speaker: Matthew Lebo, PhD (he/him/his) – Lab for Molecular Medicine, Mass General Brigham Personalized Medicine
AdvocacyInherited ConditionsMolecular Methodologies & Technologies
CE: 1.50
Saturday, Nov 18th
1:15 PM - 1:45 PM MST
AMP Working Group: Standardization of Pharmacogenomics Alleles
Location: 250, Upper Concourse
Speaker: Karen Weck, MD (she/her/hers) – University of North Carolina at Chapel Hill
Lab ManagementInherited ConditionsMolecular Methodologies & Technologies
CE: NOT CME/CMLE
Saturday, Nov 18th
1:45 PM - 2:15 PM MST
Panel Discussion: AMP Working Group: Standardization of Pharmacogenomics Alleles
Location: 250, Upper Concourse
Panelist: Karen Weck, MD (she/her/hers) – University of North Carolina at Chapel Hill
Panelist: Lisa V. Kalman, PhD – Centers for Disease Control and Prevention
Panelist: Stuart A. Scott, PhD – Stanford University
Panelist: Houda Hachad, PharmD. M Res. (she/her/hers) – AccessDx Laboratory
Lab ManagementInherited ConditionsMolecular Methodologies & Technologies
CE: NOT CME/CMLE
Saturday, Nov 18th
2:30 PM - 3:15 PM MST
Molecular Characterization and Classification of Aggressive B-Cell Lymphomas
Location: 355BC, Third Level
Speaker: Margaret Shipp, MD (she/her/hers) – Dana-Farber Cancer Institute
OncologyMolecular Methodologies & Technologies
CE: 1.50
Saturday, Nov 18th
2:30 PM - 3:15 PM MST
Tackling the MolDx Technical Assessment: Techniques for Successfully Completing the Assessment and Integrating the Assessment Process into Your Laboratory Validation Procedure.
Location: 250, Upper Concourse
Speaker: Ashley E. Shean, MS – Palmetto GBA
Molecular Methodologies & Technologies
CE: 1.50
Saturday, Nov 18th
3:15 PM - 4:00 PM MST
A Practical Approach to Molecular Testing in Aggressive B-Cell Lymphoma
Location: 355BC, Third Level
Speaker: Rena R. Xian, MD (she/her/hers) – Johns Hopkins University School of Medicine
OncologyMolecular Methodologies & Technologies
CE: 1.50
Saturday, Nov 18th
3:15 PM - 4:00 PM MST
Tackling the MolDx Technical Assessment: Techniques for Successfully Completing the Assessment and Integrating the Assessment Process into Your Laboratory Validation Procedure.
Location: 250, Upper Concourse
Speaker: Sarah Rapisardo, PhD – Duke University Health System
Molecular Methodologies & Technologies
CE: 1.50
Saturday, Nov 18th
4:15 PM - 4:45 PM MST
Guidelines and Standards for Classification, Interpretation and Reporting of Somatic Sequence Variants in Cancer
Location: 250, Upper Concourse
Speaker: Peter Horak, MD, PhD – National Center For Tumor Diseases
OncologyMolecular Methodologies & Technologies
CE: 1.0
Saturday, Nov 18th
4:45 PM - 5:15 PM MST
Standardized Nomenclature in Reporting Sequence Variants in Cancer
Location: 250, Upper Concourse
Speaker: Wesley Goar, PhD (he/him/his) – Nationwide Children's Hospital
OncologyMolecular Methodologies & Technologies
CE: 1.0